Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...

A research team at NYU Langone Health and Sage Bionetworks has been awarded a $25 million grant to establish the data hub and coordinating center for the National Institutes of Health's ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...

Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies ...

Non-animal testing methods could save drugmakers time and money, officials say ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...

The US Food and Drug Administration (FDA) recently announced a strategic roadmap to phase out animal testing requirements for certain drug products, starting with monoclonal antibodies. This shift ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...